Blog
RSS FeedPosted by Michael Wonder on 29 Jun 2020
IMC responds to Federal Court decision regarding PMPRB regulatory changes
29 June 2020 - Innovative Medicines Canada released the following statement today in response to the Federal Court of Canada’s ...
Posted by Michael Wonder on 25 Jun 2020
Consultation on CADTH’s drug reimbursement review procedures
25 June 2020 - CADTH is inviting stakeholder feedback on a revised procedure for its drug reimbursement review processes (i.e., pan-Canadian ...
Posted by Michael Wonder on 25 Jun 2020
Sandoz Canada launches the biosimilars generation
25 June 2020 - Campaign provides needed, fact-based, information for patients, healthcare providers and Canadians about biosimilar medicines in Canada. ...
Posted by Michael Wonder on 22 Jun 2020
PMPRB publishes new draft guidelines, launches 30 day consultation
22 June 2020 - As reported earlier this month, the Patented Medicine Prices Review Board has published a new draft ...
Posted by Michael Wonder on 20 Jun 2020
This drug can treat 90 per cent of cystic fibrosis patients, but it's not available in Canada
19 June 2020 - Struggling to breathe is one of the main symptoms of the novel coronavirus that has recently ...
Posted by Michael Wonder on 18 Jun 2020
Vertex and Canada hold talks over cystic fibrosis drug, but a deal for newer medicine remains out of reach
18 June 2020 - The icy relationship between Vertex Pharmaceuticals and the Canadian government is showing signs of thawing a ...
Posted by Michael Wonder on 15 Jun 2020
Rising costs explain why Canada is switching to biosimilars
15 June 2020 - Following in the footsteps of British Columbia, other Canadian provinces are working to implement their own biosimilars ...
Posted by Michael Wonder on 14 Jun 2020
30 day limit on prescription refills lifted in most provinces
12 June 2020 - Most Canadian provinces have now eased their restrictions on the supply of prescription drugs. ...
Posted by Michael Wonder on 03 Jun 2020
CADTH publishes final recommendation for Crysvita
1 June 2020 - CADTH has completed its assessment of burosumab for the treatment of patients with X-linked hypophosphatemia. ...
Posted by Michael Wonder on 02 Jun 2020
Local mother, daughter 'getting loud' for cystic fibrosis and the need for lifesaving medication
31 May 2020 - Beth and Madi Vanstone have been working tirelessly to help other cystic fibrosis patients and other Canadians ...
Posted by Michael Wonder on 01 Jun 2020
Canada's new drug price rules pushed to next year
1 June 2020 - Canada's drug pricing agency said on Monday that new regulations aimed at lowering costs would come ...
Posted by Michael Wonder on 26 May 2020
B.C. mom’s drug pricing petition on behalf of son garners thousands of signatures
26 May 2020 - Petition geared to gaining access to new medicines drew support of Chilliwack-Hope MP Mark Strahl. ...
Posted by Michael Wonder on 25 May 2020
CADTH sees green for Beovu
25 May 2020 - CADTH has published its final recommendation for Novartis' Beovu. ...
Posted by Michael Wonder on 21 May 2020
CADTH posts final recommendation for Entyvio
21 May 2020 - CADTH has completed its consideration of subcutaneous vedolizumab for the treatment of adult patients with moderately to ...
Posted by Michael Wonder on 21 May 2020
Canada grapples with drug price escalation
20 May 2020 - In July 2020 Canada will implement a series of reforms to help bring runaway drug prices under ...